Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.58 |
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.57 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.57 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.57 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.57 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.57 |
| ▸ | HRH1 | P35367 | 1/20 | 0.57 |
| ▸ | DRD3 | P35462 | 1/20 | 0.57 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.55 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valpromide SCHEMBL28307837 | 0.97 | CA2 (0.56) | CA2CA1HDAC1HDAC2CHRM1 | |
| Valpromide SCHEMBL30601110 | 0.97 | CA2 (0.56) | CA2CA1HDAC1HDAC2CHRM1 | |
| Valpromide SCHEMBL3020937 | 0.97 | CA2 (0.56) | CA2CA1HDAC1HDAC2CHRM1 | |
| SCHEMBL14571349 | 0.90 | CA2 (0.68) | CA2CA1HDAC1HDAC2CHRM1 | |
| Valproic Acid SCHEMBL3336542 | 0.90 | CHRM1 (0.76) | CA2CA1HDAC1HDAC2CHRM1 | |
| SCHEMBL6947583 | 0.90 | CA2 (0.75) | CA2CA1HDAC1HDAC2CHRM1 | |
| SCHEMBL7859211 | 0.90 | CA2 (0.50) | CA2CA1HDAC1HDAC2CHRM1 | |
| SCHEMBL10776270 | 0.90 | CA2 (0.50) | CA2CA1HDAC1HDAC2CHRM1 | |
| SCHEMBL3349103 | 0.90 | CA2 (0.75) | CA2CA1HDAC1HDAC2CHRM1 | |
| SCHEMBL276427 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 3640 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12544347-B2 | Anti-cancer combination and a method of therapy using the combination | NATIONAL CENTRE FOR CELL SCIENCE (IN) | 2026-02-10 | — | — | US | claimed |
| EP-4648773-A1 | POTASSIUM CHANNEL BLOCKERS OR DERIVATIVES THEREOF FOR PREVENTING, ALLEVIATING, AND/OR TREATING MORBIDITY AND MORTALITY INDUCED BY PATHOGENS OR OTHER INDUCERS OF IMMUNE EXHAUSTION AND/OR EXCESS IMMUNE ACTIVATION | University of Rochester (US) | 2025-11-19 | — | — | EP | claimed |
| US-20250346555-A1 | METHOD FOR CO-PRODUCING VALPROAMIDE AND SODIUM VALPROATE | HUNAN XIANGZHONG PHARMACEUTICAL CO LTD (CN) | 2025-11-13 | — | — | US | claimed |
| CN-115968358-B | Device for forming a cone for accommodating a needle in a syringe, method for manufacturing a cone for accommodating a needle in a syringe, and syringe thereof | 斯蒂瓦那托集团股份公司 | 2025-05-23 | — | — | CN | claimed |
| EP-4551217-A1 | POTASSIUM CHANNEL BLOCKERS OR DERIVATIVES THEREOF FOR PREVENTING, ALLEVIATING, AND/OR TREATING TISSUE DYSFUNCTION CAUSED BY TOXIC INSULTS | University of Rochester (US) | 2025-05-14 | — | — | EP | claimed |
| US-12285488-B2 | Oral dosage form containing theobromine-free cocoa | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2025-04-29 | — | — | US | claimed |
| EP-3518975-B1 | FORMULATION COMPRISING FENFLURAMINE AND CANNABIDIOL AND ITS USE IN THE TREATMENT OF SEIZURES | ZOGENIX INTERNATIONAL LTD (GB) | 2025-04-09 | — | — | EP | claimed |
| CN-118373735-B | Valproic acid prepared by cyanoacetic acid ester method | 湖南省湘中制药有限公司 | 2025-02-21 | — | — | CN | claimed |
| EP-3846789-B1 | COMPOSITION COMPRISING HISTONE DEACETYLASE INHIBITOR AND ESTROGEN RECEPTOR ANTAGONIST FOR USE IN A METHOD OF TREATMENT OF CANCER | NAT CENTRE FOR CELL SCIENCE (IN) | 2025-01-29 | — | — | EP | claimed |
| CN-118948849-A | Medicine for preventing and treating diseases related to anti-obesity effect | 盐野义制药株式会社 | 2024-11-15 | — | — | CN | claimed |
| US-5707663-A | Sustained antiepileptic therapy | ALZA CORPORATION (US) | 1998-01-13 | — | — | US | claimed |
| WO-1994027587-A2 | SUSTAINED ANTIEPILEPTIC THERAPY | ALZA CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| EP-0505014-A2 | Novel tetracyclic compounds having anti-allergic and anti-asthmatic activities, their preparation and use | Sankyo Company Limited (JP) | 1992-09-23 | — | — | EP | claimed |
| EP-0442012-A1 | Sustained release compositions containing valproic acid | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1991-08-21 | — | — | EP | claimed |
| US-4913906-A | DRUG DELIVERY; UNIFORM MIXTURE WITH POLYMER; ALSO SALTS, AMIDES, ESTERS | ABBOTT LABORATORIES | 1990-04-03 | — | — | US | claimed |
| US-4854973-A | SHORT CHAIN CHLORINATED SOLVENTS | NCH CORPORATION (US) | 1989-08-08 | — | — | US | claimed |
| EP-0205362-A1 | Quinolyl glycinamide derivatives, process for their preparation and their pharmaceutical use as psychotropes | SANOFI (FR) | 1986-12-17 | — | — | EP | claimed |
| EP-0028940-B1 | ANTIARRHYTHMIC TETRAHYDRONAPHTHALENE DERIVATIVES | E.R. Squibb & Sons, Inc. (US) | 1983-09-07 | — | — | EP | claimed |
| EP-0024682-B1 | PROCESS FOR THE PREPARATION OF N-PROPYL-N-PROPYLIDENE ACETAMIDE OR DI-N-PROPYL ACETAMIDE | Consortium für elektrochemische Industrie GmbH (DE) | 1982-12-22 | — | — | EP | claimed |
| EP-0024682-A1 | Process for the preparation of n-propyl-n-propylidene acetamide or di-n-propyl acetamide | Consortium für elektrochemische Industrie GmbH (DE) | 1981-03-11 | — | — | EP | claimed |